AI-powered digital pathology is redefining modern cancer care by extending clinical-grade insights beyond the microscope and enabling standardized, pixel-level analysis to support scalable cancer diagnostics anytime, anywhere.
Albuquerque, NM, March 3, 2026 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces surpassing the 3,000th installation of HALO software worldwide.
23 April 2026 | Learn how HALO and HALO AI enable quantitative image analysis, turning complex tissue data into actionable insights
Getting Started with AI-Powered HALO Image Analysis Read More »
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily pathology practice.
KLAS Recognition as a Catalyst for What Comes Next Read More »
16 April 2026 | Learn about the exciting new features in the 2.5 versions of HALO AP®!
HALO AP 2.5 Sneak Peek Webinar Read More »
31 March 2026 | Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images!
Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis Read More »
Albuquerque, NM, February 12, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for top customer-rated performance in the European digital pathology market.
HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories Read More »
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.
5 March 2026 | Learn how to develop your own AI algorithms for segmentation, classification, and more using HALO AI
Getting Started with HALO AI Read More »
17 March 2026 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at The Hilton Frankfurt Airport on 17 March from 11:00 – 16:00.
Indica Labs’ Frankfurt HALO® User Group Meeting 2026 Read More »
